Epigenetics: A Molecular Link Between Environmental Factors and Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 116 of the 117 references it cites were found in a registry or an index.
Abstract
A lthough obesity, reduced physical activity, andaging increase susceptibility to type 2 diabetes,many people exposed to these risk factors donot develop the disease. Recent genome-wide association studies have identified a number of genetic variants that explain some of the interindividual variation in diabetes susceptibility (1–5). There is also a growing body of literature suggesting a role for epigenetic factors in the complex interplay between genes and the environ-ment. Nevertheless, our knowledge about the molecular mechanisms linking environmental factors and type 2 diabetes still remains limited. This perspective will pro-vide some insights into epigenetic mechanisms associated with type 2 diabetes. An overview of epigenetic regulation. Although there is no uniform definition of epigenetics, it has been de-scribed as heritable changes in gene function that occur without a change in the nucleotide sequence (6). Epige-
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, changes in human epigenome have been associated with processes related to adaptation and evolution (64, 65), and have also been linked to several diseases, such as cancer (66), type 2 diabetes (67), and autoimmune rheumatic disorders, such as systemic lupus erythematosus (SLE) (68).”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [67]
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, epigenetic mechanisms may also contribute to these patterns because reduced expression parallels increased DNA methylation of both the COX7A1 promoter (136) and NDUFB6 (137, 139).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Reddy, M. A., Villeneuve, L. M., Wang, M., Lanting, L. L., & Natarajan, R. D. (2008) · Circulation Research · doi:10.1161/circresaha.108.175190 · Cited by 83 · cited 3×
“, IL-6 and MCP-1, in parallel with decreased levels of the H3K9me3 methyltransferase Suv39h1 and a histone demethylase, the lysine-specific demethylase 1 (LSD1) (103,104).”
BackgroundRetractedChromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · cited 1×
“COX7A1, which is part of complex 4 of the respiratory chain and which shows decreased expression in diabetic muscle, is a target of age-related DNA methylation (23,34).”
BackgroundSelf-citationEffects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · cited 1×
“risk of macrovascular complications (106,107).”
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
Self-citationPersistent epigenetic differences associated with prenatal exposure to famine in humans
Heijmans, B. T., Tobi, E. W., Stein, A. D., Putter, H., Blauw, G. J., Susser, E. S., Slagboom, P. E., & Lumey, L. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806560105 · Cited by 3,082
DNA methylation landscapes: Provocative insights from epigenomics
Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039 · cited 1×
“New techniques have made it easier to analyze DNA methylation and histone modifications on a genome-wide scale (19,20).”
BackgroundBird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011 · cited 1×
“Although there is no uniform definition of epigenetics, it has been described as heritable changes in gene function that occur without a change in the nucleotide sequence (6).”
BackgroundA genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Cited by
Items 401–500 of 655
Methylation of Tcf712 promoter by high‐fat diet impairs β‐cell function in mouse pancreatic islets
Hu, Y., Shi, P., He, K., Zhu, Y., Yang, F., Yang, M., He, B., & Mao, X. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2980 · Cited by 10
Udesen, P. B., Sørensen, A. E., Joglekar, M. V., Hardikar, A. A., Wissing, M. L., Englund, A. L. M., & Dalgaard, L. T. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0478-7 · Cited by 10
Epigenetic Epidemiology of Complex Diseases Using Twins
Tan, Q. (2013) · Medical Epigenetics · doi:10.1159/000354285 · Cited by 11
Diabetes and cardiometabolic risk factors in C ambodia: R esults from two screening studies
Wagner, J. A., Naranjo, D. M., Khun, T., Seng, S., Horn, I. S., Suttiratana, S. C., & Keuky, L. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12570 · Cited by 10
“Studies from the Dutch Hunger Winter(25) and the Jewish holocaust(26) suggest that exposure to severe nutritional conditions may cause epigenetic changes that increase the risk for diabetes.(27) Finally, in recent decades the traditional reliance on brown rice for the bulk of the Cambodian diet has shifted to lower-fi…”
BackgroundRNA as the substrate for epigenome‐environment interactions
Mattick, J. S. (2010) · BioEssays · doi:10.1002/bies.201090026 · Cited by 10
Antidepressants and Risk of Type 2 Diabetes Mellitus: A Population-Based Nested Case-Control Study
Kuo, H.-Y., Chen, H., Lee, C., Lee, H.-H., Kuo, C.-J., Hsu, C., Pan, C., Su, N., & Chu, C. (2020) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001228 · Cited by 9
Removal of epigenetic repressive mark on inflammatory genes in fat liver
Zhang, L., Wang, C., Xu, Q., Mu, Z., Lin, X., Li, L., Xiao, Y., Wu, M., & Chen, M. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16252 · Cited by 9
TFPI2 hypermethylation promotes diabetic atherosclerosis progression through the Ap2α/PPARγ axis
Xia, Z., Zhou, C., Hong, Y., Li, F., Zhang, W., Ji, H., Xiao, Y., Li, S., Li, S., Lu, X., et al. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2024.11.010 · Cited by 9
Qigong for the Management of Type 2 Diabetes Mellitus
Sun, G., Osgood, C., & Lilly, H. R. (2017) · InTech eBooks · doi:10.5772/67065 · Cited by 9
Genome‑wide DNA methylation profiling in a rat model with vascular dementia
Park, J., Kim, Y. J., Song, M. K., Lee, J., & Kim, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8990 · Cited by 11
Brown Fat Dnmt3b Deficiency Ameliorates Obesity in Female Mice
Li, F., Cui, X., Jing, J., Wang, S., Shi, H., Xue, B., & Shi, H. (2021) · Life · doi:10.3390/life11121325 · Cited by 9
Wang, X., Liu, J., Wang, Q., & Chen, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1122047 · Cited by 12
Sosa-Larios, T. C., Ortega-Márquez, A. L., Rodríguez‐Aguilera, J. R., Vázquez-Martínez, E. R., Domínguez‐López, A., & Morimoto, S. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1138564 · Cited by 12
Jiang, C. H., Hu, Y., Wang, S., & Chen, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1145067 · Cited by 9
“Recent accumulative evidence has proven the significant roles of epigenetic aberrations in the initiation and progression of T2DM (2, 3).”
BackgroundMethodDas, S. K. (2014) · Diabetes · doi:10.2337/db14-0757 · Cited by 9
Zhang, L., Zhu, C., Heidari, M., Dong, K., Chang, S., Xie, Q., & Zhang, H. (2020) · Veterinary Research · doi:10.1186/s13567-020-00746-4 · Cited by 10
Aberrant DNA methylation involved in obese women with systemic insulin resistance
Zhang, S., Wang, Y., Yang, Y., & Zheng, H. (2018) · Open Life Sciences · doi:10.1515/biol-2018-0024 · Cited by 9
Malipatil, N. S., Lunt, M., Narayanan, R. P., Siddals, K. W., Moreno, G., Gibson, M., Gu, H. F., Heald, A. H., & Donn, R. P. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13270 · Cited by 10
Tribbles homologue 3 (TRIB3) and the insulin-resistance genes in type 2 diabetes
Bèguinot, F. (2010) · Diabetologia · doi:10.1007/s00125-010-1824-7 · Cited by 9
“Indeed, the importance of considering epigenetic modifications for unravelling the genetic architecture of type 2 diabetes is receiving increasing attention [23].”
BackgroundEPIGENETICS: EFFECT OF ENVIRONMENTAL FACTORS ON HUMAN GENOME
Sherzay, N., & Chitakar, E. (2016) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 10
Nursanti, O., Wardani, I., & Hadisoebroto, G. (2022) · Jurnal Farmasi Higea · doi:10.52689/higea.v14i1.469 · Cited by 8
The impact of site-specific DNA methylation in KCNJ11 promoter on type 2 diabetes
Zhu, M., Huang, Q., Li, H., Zhao, Y., Guo, H., Wang, T., Liu, X., Huang, Y. L., Hu, J., Fang, C., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39934 · Cited by 10
Zhou, M., Han, L., Zhang, J., Hao, D., Cai, Y., Wang, Z., Zhou, H., & Sun, J. (2014) · Molecular BioSystems · doi:10.1039/c4mb00339j · Cited by 8
Qie, R., Han, M., Huang, S., Li, Q., Liu, L., Zhang, D., Cheng, C., Zhao, Y., Liu, D., Qin, P., et al. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107829 · Cited by 9
Huang, Y.-C., Tsai, T.-C., Chang, C.-H., Chang, K.-T., Ko, P., & Lai, L. (2021) · Toxins · doi:10.3390/toxins13120873 · Cited by 9
Li, Z., Song, Y., Zhao, L., Liu, S., Yi, S., Zhang, Z., Yu, T., & Li, Y. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00615-1 · Cited by 7
Assisted reproductive technology (ART) and epigenetic modifications in the placenta
Sundrani, D. P., & Joshi, S. (2021) · Human Fertility · doi:10.1080/14647273.2021.1995901 · Cited by 9
“The three epigenetic mechanisms of gene regulation, which collectively make up the epigenome, are DNA methylation, histone modification, and regulation of non-coding RNAs (ncRNAs) (Ling & Groop, 2009).”
BackgroundKesharwani, D., Kumar, A., Rizvi, A., & Datta, M. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.08.013 · Cited by 9
Targeting histone methylation and demethylation for non-alcoholic fatty liver disease
Du, Y., He, Z., Jin, S., Jin, G. Y., Wang, K., Yang, F., & Zhang, J. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107698 · Cited by 7
New insights in the regulation of skeletal muscle PGC-1α by exercise and metabolic diseases
Pérez‐Schindler, J., & Handschin, C. (2013) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.12.002 · Cited by 9
Adverse Skeletal Muscle Adaptations in Individuals Born Preterm—A Comprehensive Review
Dobson, N. L., Levitt, D. E., Luk, H. Y., & Vellers, H. L. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050276 · Cited by 7
“Among the numerous metabolic intermediates that influence chromatin modifications, NAD + and acetyl-CoA are among the most well characterized due to their association with diseases such as diabetes [31,94,95] and cancer [96].”
Backgroundβ‐Cell mass and function in human type 2 diabetes
Marchetti, P., & Ferrannini, E. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch24 · Cited by 12
An Overview on Germinated Brown Rice and its Nutrigenomic Implications
Imam, M. U., & Ismail, M. (2015) · Wiley eBooks · doi:10.1002/9781118930458.ch39 · Cited by 7
Eriksen, R., Gibson, R., Aresu, M., Heard, A., Chan, Q. M., Εvangelou, Ε., Gao, H., Elliott, P., & Frost, G. S. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.74 · Cited by 7
The histone methyltransferase Suv39h regulates 3T3-L1 adipogenesis
Jia, J., Li, F., Zha, L., Yang, X., Wu, R., Wang, S., Xue, B., & Shi, H. (2020) · Adipocyte · doi:10.1080/21623945.2020.1795422 · Cited by 7
“diets) to obesity [8,9] where adipogenesis figures in prominently.”
BackgroundMetabolic Programming: Origin of Non-Communicable Diseases in Early Life Nutrition
Kiani, A., & Nielsen, M. O. (2012) · Intern J Endocrinol Metab · doi:10.5812/kowsar.1726913x.3366 · Cited by 10
Sultana, A., Mitu, S. J., Pathan, M. N., Uddin, M. N., Uddin, M. A., & Aryal, S. (2023) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2023.107974 · Cited by 6
Methyl-CpG/MBD2 Interaction Requires Minimum Separation and Exhibits Minimal Sequence Specificity
Moreland, B., Oman, K. M., Curfman, J. P., Yan, P. S., & Bundschuh, R. A. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.11.014 · Cited by 6
“The pattern of methylated nucleotides in mammalian genomic DNA (in humans, this is most commonly the methylated cytosines of a CpG) changes with age (1); is affected by the environment (2–4) and disease (5,6); and, in an aberrant form, is a hallmark of many forms of cancer (7–9).”
BackgroundMethodZhou, J., & Shi, Y. (2017) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2017.2695187 · Cited by 6
i4mC‐EL: Identifying DNA N4‐Methylcytosine Sites in the Mouse Genome Using Ensemble Learning
Li, Y., Zhao, Z., & Teng, Z. (2021) · BioMed Research International · doi:10.1155/2021/5515342 · Cited by 6
The Nutrigenome and Gut Microbiome: Chronic Disease Prevention with Crop Phytochemical Diversity
Daniell, E. L., & Elizabeth, P. (2012) · InTech eBooks · doi:10.5772/33500 · Cited by 6
“Alterations in methylation patterns have been associated with various disease states including cancer, Type 2 diabetes, and Alzheimer’s Disease (Coppieters & Dragunow, 2011; Hirst & Marra, 2009; Ling & Groop, 2009; Martin-Subero & Esteller, 2011).”
DNA Methylation for Prediction of Adverse Pregnancy Outcomes
Sundrani, D. P., Khot, V., & Joshi, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801899-6.00018-8 · Cited by 10
Epigenetic Biomarkers of Disease
Voyias, P. D., Patel, A. J., & Arasaradnam, R. P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803239-8.00010-7 · Cited by 12
Detection of DNA Methylation Changes in Body Fluids
Liloglou, T., & Field, J. K. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380864-6.00006-7 · Cited by 6
“There is also an increasing line of evidence implicating DNA methylation deregulation in many human nonmalignant diseases including neurodegenerative (Kronenberg et al., 2009; Wang et al., 2010), cardiovascular (Gluckman et al., 2009), and diabetes (Ling and Groop, 2009).”
BackgroundBailbé, D., Liu, J., Gong, P., & Portha, B. (2021) · Biomolecules · doi:10.3390/biom11020179 · Cited by 5
The Role of Epigenetic Regulation in Diabetes and Its Complications*
Ling, H., Hu, B. J., Feng, S., Liao, D.-F., & Wen, G. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2011.00230 · Cited by 5
Mechanism of Active DNA Demethylation: Recent Progress in Epigenetics
Maiti, A. (2013) · Journal of Biomolecular Research & Therapeutics · doi:10.4172/2167-7956.1000e106 · Cited by 5
Epigenome-Wide Association (DNA Methylation) Study of Sex Differences in Normal Human Kidney
Joseph, S. J., George, N. I., Green-Knox, B., Nicolson, T. J., Hammons, G., Word, B. R., Huang, S. M., & Cook, B. D. L. (2017) · Journal of Drug Metabolism & Toxicology · doi:10.4172/2157-7609.1000225 · Cited by 5
A novel understanding of global DNA methylation in bobcat ( Lynx rufus )
Cantrell, B., Friedman, S., Lachance, H., Bernier, C., Murdoch, B. M., Frattini, S., Talenti, A., Crepaldi, P., & McKay, S. (2019) · Genome · doi:10.1139/gen-2019-0046 · Cited by 5
“Epigenetics is described as the heritable change in gene expression 54 that occurs without a change to the nucleotide sequence (Ling and Groop 2009).”
BackgroundDomínguez-Castro, M., Domínguez-Galicia, A., Pérez-Pérez, O., Hernández‐Pineda, J., Mancilla‐Herrera, I., Bazán‐Tejeda, M. L., Rodríguez-Cruz, L., González-Torres, M. C., Montoya-Estrada, A., Reyes-Muñoz, E., et al. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.11.029 · Cited by 5
A DNA Methyltransferase Modulator Inspired by Peyssonenyne Natural Product Structures
García‐Domínguez, P., Weiss, M., Lepore, I., Álvarez, R., Altucci, L., Gronemeyer, H., & de Lera, Á. R. (2012) · ChemMedChem · doi:10.1002/cmdc.201200366 · Cited by 5
HSPC117 Is Regulated by Epigenetic Modification and Is Involved in the Migration of JEG-3 Cells
Ma, H., Qi, M.-Y., Zhang, X., Zhang, Y., Wang, L., Li, Z.-Q., Fu, B., Wang, W., & Liu, D. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150610936 · Cited by 5
Momma, H., Sawada, S. S., Sloan, R. A., Gando, Y., Kawakami, R., Terada, S., Miyachi, M., Kinugawa, C., Okamoto, T., Tsukamoto, K., et al. (2017) · Journal of Epidemiology · doi:10.2188/jea.je20160199 · Cited by 5
Lecamwasam, A., Mohebbi, M., Ekinci, E. I., Dwyer, K. M., & Saffery, R. (2020) · JMIR Research Protocols · doi:10.2196/16277 · Cited by 5
Multiclass classification of metabolic conditions using fasting plasma levels of glucose and insulin
Altuve, M., Alvarez, A. J., & Severeyn, É. (2021) · Health and Technology · doi:10.1007/s12553-021-00550-w · Cited by 7
“of rats ?, which could signal age-related methylation as an epigenetic factor related to type 2 diabetes [37].”
BackgroundResultPleiotropic functions and clinical importance of circulating HDL-PON1 complex
Mahrooz, A. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.04.003 · Cited by 5
Halogenation of nucleic acid structures: from chemical biology to supramolecular chemistry
Nicolau, C., Requena-Ramírez, J., González‐García, J., & Bauzá, A. (2025) · RSC Chemical Biology · doi:10.1039/d5cb00077g · Cited by 4
Wagner, J. A., Keuky, L., Lampert, R. J., Fraser-King, L., Feinn, R., Kuoch, T., & Scully, M. F. (2015) · International Journal of Behavioral Medicine · doi:10.1007/s12529-015-9468-0 · Cited by 4
Davis, G. E., & Lowell, W. E. (2013) · Clinical Epigenetics · doi:10.1186/1868-7083-5-5 · Cited by 4
“© 2013 Davis and Lowell; licensee BioMed Ce Creative Commons Attribution License (http:/ distribution, and reproduction in any medium involved, especially in the third world where obesity is a major, but not the only factor [4].”
BackgroundEpigenetyczna regulacja ekspresji genów â nowy mechanizm łączący otyłość z rozwojem cukrzycy typu 2
Dobosz, A. M., Dziewulska, A., & Dobrzyń, A. (2018) · Postępy Biochemii · doi:10.18388/pb.2018_126 · Cited by 5
Acetylated Histone Modifications: Intersection of Diabetes and Atherosclerosis
Liu, R., Li, L., Wang, Z., Zhu, J., & Ji, Y. (2023) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001516 · Cited by 4
“At Lys(9) of HH3, inhibitors of HAT can suppress the level of class II trans-activator (class II transactivator) and thus inhibit vascular in fl ammation.”
BackgroundInfluentialIntegrated Chemoinformatics Approaches Toward Epigenetic Drug Discovery
Loharch, S., Karmahapatra, V., Gupta, P. K., Madathil, R., & Parkesh, R. (2019) · Challenges and advances in computational chemistry and physics · doi:10.1007/978-3-030-05282-9_8 · Cited by 4
Asllanaj, E., Ochoa‐Rosales, C., Glišić, M., Nano, J., Muka, T., & Franco, O. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814259-2.00012-1 · Cited by 4
ENVIRONMENT-DEPENDENT HUMAN DISEASES: THE EPIGENETIC MECHANISMS OF THEIR DEVELOPMENT AND INHERITANCE
Patkin, E. L., & Софронов, Г. А. (2015) · Medical academic journal · doi:10.17816/maj1537-23 · Cited by 10
Polycystic Ovarian Syndrome in Perimenopausal Women: A Pilot Study
Chhabra, S. A., & Taori, A. (2015) · Reproductive System & Sexual Disorders · doi:10.4172/2161-038x.1000157 · Cited by 3
Ding, L., Yang, Q., Sun, Z., Liu, L., Meng, Z., Zhao, X., Tao, N., & Liu, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1002044 · Cited by 4
Hasan, N. S., Dine, H. G. E., Kamel, S. A., Hamed, M., Youssef, R. N., Hassan, E. M., Abdelrahman, A. H., Musa, N. I., Ali, A., & Awadallah, E. A. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110677 · Cited by 3
Understanding Interindividual Epigenetic Variations in Obesity and Its Management
Patel, S., Choksi, A., & Chattopadhyay, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420135-4.00015-2 · Cited by 3
Chinese Medical Therapies for Diabetes, Infertility, Silicosis and the Theoretical Basis
Li, X.-T. (2017) · InTech eBooks · doi:10.5772/63167 · Cited by 3
Mann, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00015-1 · Cited by 3
The Role of Epigenetic Modifications in Cardiometabolic Diseases
Braun, K. V. E., Portilla, E. C., Chowdhury, R., Nano, J., Troup, J., Voortman, T., Franco, O. H., & Muka, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811060-7.00017-6 · Cited by 3
Epigenetic understanding of pain mechanisms and modern treatment perspectives
Jośko-Ochojska, J. (2019) · Ból · doi:10.5604/01.3001.0013.4582 · Cited by 3
Effect of obesity on pulmonary vascular hemodynamics
Zıyrek, M., & Duran, M. (2020) · Journal of Cardiovascular Echography · doi:10.4103/jcecho.jcecho_70_19 · Cited by 3
Robinetin Alleviates Metabolic Failure in Liver through Suppression of p300-CD38 Axis
Song, J., Kim, H., Lee, J., Hong, S.-P., Chung, M., Lee, Y.-G., Park, J. H., Choi, H., & Hwang, J. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2023.061 · Cited by 3
“Aberrant histone acetylation contributes to the development of NAFLD and IR (Ling and Groop, 2009; Bricambert et al ., 2010).”
BackgroundAjmire, P. P., & Mirchapure, V. G. (2024) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt/ijisrt24sep941 · Cited by 4
Type 2 diabetes: the evolution of a disease
Lebovitz, H. E. (2012) · The British Journal of Diabetes · doi:10.1177/1474651412470289 · Cited by 3
Basic Experimental and Clinical Advances in the Mechanisms Underlying Abnormal Pregnancy Outcomes
Regnault, T. R. H., Nijland, M. J., Budge, H., & Morrison, J. L. (2013) · Journal of Pregnancy · doi:10.1155/2013/327638 · Cited by 3
Lehane, D., Cunliffe, V. T., Mitchell, C. A., & Burton, C. D. (2017) · British Journal of General Practice · doi:10.3399/bjgp17x693977 · Cited by 3
Айтбаев, К. А., Калиевна, М. С., Murkamilov, I. T., Fomin, V. V., Kudaibergenova, I., Абдилалимовна, М. Ж., & Yusupov, F. A. (2021) · Bulletin of Science and Practice · doi:10.33619/2414-2948/66/17 · Cited by 2
Future Directions and Emerging Research in Metabolic Syndrome
Patel, C. A., Chaudagar, K. K., Mehta, A., & Gandhi, T. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-75686-3_26 · Cited by 4
GPCR-Mediated Cell Intelligence: A Potential Mechanism for Survival and Long-Term Health
Craig, C. J., Boeringer, T., Pardo, M., Pozo, A. D., & Maudsley, S. R. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48020127 · Cited by 2
“For example, in type 2 diabetes, pancreatic beta cells exposed to chronic hyperglycemia develop epigenetic changes that impair insulin secretion, perpetuating metabolic dysfunction [68].”
Milluzzo, A., Maugeri, A., Barchitta, M., Lio, R. M. S., Rocca, D., Marino, A., Frittitta, L., Sciacca, L., & Agodi, A. (2026) · Nutrients · doi:10.3390/nu18121970 · Cited by 3
The Role of Inflammation in Type 2 Diabetes-Driven Atherosclerosis
Enns, J. E., Taylor, C. G., & Zahradka, P. C. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9317-4_13 · Cited by 3
Non-alcoholic fatty liver disease: an epigenetic view of pathogenesis and a new treatment options
Айтбаев, К. А., Murkamilov, I. T., Абдилалимовна, М. Ж., Fomin, V. V., Kudaibergenova, I., & Yusupov, F. A. (2022) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-203-7-171-176 · Cited by 2
Bartiromo, M., Nardolillo, M., Ferrara, S., Russo, G., del Giudice, E. M., & Sessa, A. D. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2242245 · Cited by 2
Papadimitriou, I. D. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1407753 · Cited by 2
“Epigenetic modi fi cations involve changes of gene expression that occur without any alternations to the DNA sequence and include DNA methylation, histone modi fi cations, and microRNA expression (Ling and Groop, 2009).”
BackgroundDnmt3b Deficiency in Adipocyte Progenitor Cells Ameliorates Obesity in Female Mice
Huang, Y., Yu, S., Cao, Q., Jing, J., Tang, W., Xue, B., & Shi, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020861 · Cited by 2
Epigenetic Modifications and Type 2 Diabetes in Humans
Ling, C. (2014) · Frontiers in diabetes · doi:10.1159/000362470 · Cited by 2
Self-citationThe Multifaceted Roles of LncRNAs in Diabetic Complications: A Promising Yet Perplexing Paradigm
Biswas, S., & Chakrabarti, S. (2020) · RNA technologies · doi:10.1007/978-3-030-44743-4_19 · Cited by 2
Genetic and Epigenetics of Type 2 Diabetes
Coletta, D. K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.02002-5 · Cited by 2
Epigenetics of Human Obesity: A Link Between Genetics and Nutrition
Albuquerque, D., Manco, L., & Nóbrega, C. (2014) · Springer eBooks · doi:10.1007/978-3-319-12766-8_8 · Cited by 4
Rönn, T., Ling, C., & Researcher, A. (2014) · US Endocrinology · doi:10.17925/use.2014.10.01.64 · Cited by 2
Self-citationRole of histone modification in 12-lipoxygenase-associated p21 gene regulation
Cui, Y., Liu, N., Ma, F., Sun, W., Wu, H., Xu, Z., & Yuan, H. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5724 · Cited by 2
“…glucose tolerance and the body has already formed metabolic memory, presenting potential hidden risks for the occurrence of DM and its complications (14-16), however, it also indicates that abnormal epigenetic modifications may be involved in the pathogenesis of DM and its complications (17,18).”
Gautam, S. (2018) · Journal of Clinical Epigenetics · doi:10.21767/2472-1158.100086 · Cited by 2
Epigenetics of Diabetes in Humans
Nano, J., Portilla-Fernández, E., Troup, J., Ghanbari, M., Franco, O. H., & Muka, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00016-9 · Cited by 3
Le diabete de type 2: voyage au coeur d'une maladie complexe.
Scheen, A. J., & Paquot, N. (2012) · RMLG. Revue médicale de Liège · Cited by 2
Diabetes Microvascular Complications: An Overview of Epigenetic Modifications
Aggarwal, N., & Kare, P. K. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94642 · Cited by 3
Chen, G., Li, Z., Sang, Q., Wang, L., Wuyun, Q., Wang, Z., Chen, W., Yu, C., Lian, D., & Zhang, N. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s402687 · Cited by 2
Epigenetics of diabetes in humans
Kowluru, R. A., & Kowluru, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18661-5.00009-9 · Cited by 2
Vil trening in vivo prege skjelettmuskelceller in vitro
Lund, J. (2013) · NORA - Norwegian Open Research Archives · Cited by 2
Metadata
- Authors
- Ling, C., & Groop, L.
- Affiliations
- Lund University (SE)
- Corresponding author
- Ling, Charlotte
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-12-01
- Volume
- 58
- Issue
- 12
- Pages
- 2718-2725
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2780862
- OpenAlex
- W2164575981
- Cited by
- 617
- References
- 117
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 20 · 2023: 35 · 2022: 24 · 2021: 35 · 2020: 39 · 2019: 50 · 2018: 49 · 2017: 56 · 2016: 44 · 2015: 58 · 2014: 41 · 2013: 49 · 2012: 36
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Eli Lilly and Company
- Lunds Universitet
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- epigenetics, type 2 diabetes, environmental risk factors, gene-environment interaction, obesity, physical inactivity, aging, genetic susceptibility, epigenetic regulation
- MeSH terms
- Aging, Animals, Diabetes Mellitus, Type 2, Energy Metabolism, Food, Histones, Humans, Infant, Newborn, Obesity, Risk Factors, Transcription, Genetic, Exercise, DNA Methylation, MicroRNAs, Epigenesis, Genetic, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.